|
Palonosetron
- Palonosetron (palonosetron hydrochloride) is a second generation 5-HT3 receptor antagonist developed for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with cancer.
- It has a long half-life of 40 hours and it binds more tightly and in a different way to the receptor as compared to other available drugs of the same class. It is top seller in more than 50 countries worldwide as Aloxi®, Onicit®, Paloxi®.
- Read more: www.aloxi.net
|
|
|
|
|
|
|
|
|